SCHEMBL29620726

SCHEMBL29620726

Oc1ccc(I)nc1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL130102 1.00
SCHEMBL29769758 0.74
SCHEMBL17885770 0.74
SCHEMBL29870764 0.74
SCHEMBL6707376 0.74
SCHEMBL2144037 0.74
SCHEMBL7940451 0.72
SCHEMBL9062727 0.70 KMT2A (0.44)
SCHEMBL15614405 0.70
SCHEMBL3951147 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024240062-A1 PYRIDINE-PYRROLO DERIVATIVE AND USE THEREOF IN DRUGS 广东东阳光药业股份有限公司 2024-11-28 WO disclosed
US-20240300938-A1 COMPOUNDS AND USES THEREOF JANSSEN PHARMACEUTICA NV (BE) 2024-09-12 US disclosed
WO-2022211812-A1 ANTIVIRAL HETEROCYCLIC COMPOUNDS ENANTA PHARMACEUTICALS, INC. (US) 2022-10-06 WO disclosed
EP-4037688-A1 ANTIVIRAL HETEROCYCLIC COMPOUNDS Enanta Pharmaceuticals, Inc. (US) 2022-08-10 EP disclosed
WO-2022086840-A1 HETEROCYCLIC COMPOUNDS AS ANTI-VIRAL AGENTS ENANTA PHARMACEUTICALS, INC. (US) 2022-04-28 WO disclosed